Amplifon to Acquire GN Hearing Business in $2.6B Deal
COPENHAGEN, Denmark, March 16, 2026 GN Store Nord A/S has entered into a definitive agreement to sell its Hearing...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Mergers & Acquisitions for New Therapy
COPENHAGEN, Denmark, March 16, 2026 GN Store Nord A/S has entered into a definitive agreement to sell its Hearing...
PLEASANTON, CA — March 10, 2026 Veeva Systems announced the acquisition of Ostro, a leading AI-driven brand engagement platform...
DEERFIELD, Illinois & BARCELONA, Spain — March 11, 2026 The global pharmaceutical industry marked an important strategic development as...
Boston, USA & Shanghai, China – March 9, 2026 Rapport Therapeutics and Tenacia Biotechnology have announced a strategic collaboration...
March 06, 2026 — Suresnes, France & Brisbane, California, USA Global pharmaceutical group Servier and oncology-focused biotech Day One...
NEW HAVEN, Conn. & SAN DIEGO — March 2, 2026 Rallybio Corporation and Candid Therapeutics announced a definitive merger...
NEWPORT BEACH, Calif., March 3, 2026 Investment firm NorthStrive Fund II LP has called on enVVeno Medical Corporation to...
ANN ARBOR, Mich. & HENDERSON, Nev., March 3, 2026 Esperion Therapeutics and Corstasis Therapeutics Inc. announced a definitive agreement...
BASEL, Switzerland – February 27, 2026 Novartis AG has successfully completed its acquisition of Avidity Biosciences, Inc., strengthening its...
WARREN, N.J. and ROYAL OAK, Mich., February 26, 2026 Tevogen Bio Holdings Inc. (Nasdaq: TVGN) has signed a non-exclusive,...
